Hematology

1. In this phase 1 trial involving patients with triple-class refractory multiple myeloma, treatment with anitocabtagene autoleucel led to a...

1. In this analysis of data from over two dozen individuals with Wiskott-Aldrich syndrome, treatment with etuvetidigene autotemcel (etu-cel) was...

1. In this prospective cohort study, mortality risk was higher among participants with hemoglobin concentrations below, 0 to 1 g/dL...

1. In this case series of severe acquired methemoglobinemia among migrants to Italy, prolonged skin exposure to fuel-contaminated seawater was...

1. In this randomized phase 2 trial involving previously untreated adults with acute myeloid leukemia, azacitidine–venetoclax improved event-free survival compared...

1. In this phase 3 randomized controlled trial, a single infusion of lonvoguran ziclumeran reduced hereditary angioedema attacks by 87%...

1. The antithrombotic agents aspirin, clopidogrel, and rivaroxaban were non-inferior to metoprolol for responder rate in participants with patent foramen...

1. Hematologic inflammatory indices in emergency department patients with COVID-19 showed an age-dependent prognostic performance for 30-day mortality, with systemic...

1. In adolescents and adults with hemophilia A, subcutaneous Mim8 prophylaxis reduced treated bleeding events versus on-demand therapy and versus...

1. In this phase 2 randomized controlled trial, weekly subcutaneous mezagitimab was well-tolerated and associated with symptomatic improvement among patients...